SynthesisBMC oral health2025
Two novel AXIN2 variants in isolated tooth agenesis and the AXIN2-associated tooth agenesis pattern.
Synthesis in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Stem Cell-based Therapeutic and Endogenous Regeneration Approaches for Congenital Tooth Agenesis.Stem cell reviews and reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundVariants in the AXIN2 gene are associated with colorectal cancer, oligodontia-colorectal cancer syndrome, and isolated tooth agenesis. To date, only 19 AXIN2 variants have been linked to tooth agenesis. This study aimed to identify novel AXIN2 variants in individuals with isolated tooth agenesis, evaluate their pathogenicity, and summarize possible patterns of AXIN2-associated tooth agenesis through a systematic literature review.
methodsWhole-exome sequencing (WES) was performed to detect AXIN2 variants in individuals with isolated tooth agenesis. AXIN2 cDNA clone sequencing and mRNA expression analysis were performed using peripheral blood mononuclear cells (PBMCs) from carriers. Pathogenicity of the identified variants was evaluated through bioinformatic analyses, structural modeling, and in vitro functional assays. A systematic literature review was further performed to characterize the AXIN2-associated tooth agenesis pattern.
resultsTwo novel heterozygous AXIN2 variants were identified: a missense variant (c.2078C > T; p.Thr693Met) and a splicing variant (c.1060-3T > C; p.Arg354Leufs*2). Bioinformatic analyses classified the c.2078C > T variants as likely pathogenic and the c.1060-3T > C as pathogenic. Structural predictions indicated that the p.Thr693Met variant may impair RNA base pairing and disrupt protein structure, while the p.Arg354Leufs*2 variant led to a truncated protein due to premature termination. Functional assays demonstrated that p.Thr693Met aberrantly activated Wnt/β-catenin signaling in vitro, and p.Arg354Leufs*2 resulted in approximately 50% reduction of AXIN2 transcript levels in patients' PBMCs. Analysis of tooth agenesis patterns revealed that the mandibular (67.9%) and maxillary (64.1%) second premolars were the most frequently missing teeth.
conclusionsThis study expands the mutational spectrum of AXIN2-associated isolated tooth agenesis and provides in vitro functional evidence supporting the pathogenicity of the identified variants. These findings offer important insights for genetic diagnosis and counseling in affected families.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.